Open AccessEffect of COVID-19 Pandemic on Performance Measures in Acute Myocardial Infarction
Author(s) -
Miguel Alejandro Rodríguez-Ramos
Publication year - 2021
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2021.3.n1496
Subject(s) - cardiogenic shock , medicine , myocardial infarction , clinical endpoint , covid-19 , emergency medicine , pandemic , intensive care unit , shock (circulatory) , cardiology , clinical trial , disease , infectious disease (medical specialty)
Objective To assess performance measures of attention of STEMI in Coronary Intensive Care Unit in General Hospital Camilo Cienfuegos. Methods Admitted patients with STEMI, from February-April 2020, were compared with patients from similar period from 2015–2019, and patients from January 2019 to January 2020. Primary endpoint were performance measures according to the 2017 AHA / ACC Clinical Performance and Quality Measures for Adults with STEMI document, and secondary endpoint were all-cause in-hospital mortality and major acute coronary events. Results Only 35 patients were admitted from February-April 2020. When comparing with similar periods from recent years, in-hospital death (8.3 % vs. 20 %; p=0.03), major complications (38.7 % vs. 57.1 %; p=0.03), and cardiogenic shock (6.9 % vs. 17.4 %; p=0.04) were significantly higher. When comparing with 2019 and January 2020, in-hospital death (9.6 %; p=0.04), and major complications (35.8 % p=0.03) were significantly higher in February-April 2020; however, there was no difference in prevalence of cardiogenic shock (8 %; p=0.12). Conclusion COVID-19 pandemic had decreased prevalence of STEMI, as well as some performance measures of attention in this center.